Clinical Trial Update: Multi_center Study to Evaluate the Effect of N-3 Fatty Acids (OMEGA-3) on Arrhythmia Recurrence in Atrial Fibrillation [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating omega-3 fatty acids for atrial fibrillation recurrence has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• Omega-3 (omega-3 fatty acids)

Snippet

Sponsor: Montreal Heart Institute | Conditions: Atrial Fibrillation | Phase 3 | Status: COMPLETED